Stürzebecher J, Markwardt F, Vieweg H, Wagner G, Walsmann P
Pharmazie. 1984 Jun;39(6):411-3.
Isomeric compounds of N alpha-arylsulfonylated amides of omega-amidinophenyl-alpha-aminoalkylcarboxylic acids--N alpha-amidinophenylsulfonylated amides or N alpha-arylsulfonylated amidino anilides of omega-phenyl-alpha-aminoalkylcarboxylic acids, respectively--possess weak antithrombin activity as compared to the derivatives of the basic structure. Thus, the assumption is corroborated that specific enzyme-inhibitor interactions account for the high antithrombin activity of certain derivatives of omega-amidinophenyl-alpha-aminoalkylcarboxylic acids. In contrast, amidinoanilides of N alpha-substituted omega-phenyl-alpha-aminoalkylcarboxylic acids are potent inhibitors of trypsin and plasmin, their inhibitory activity approaches that of primary amides of N alpha-substituted omega-amidinophenyl-alpha-aminoalkylcarboxylic acids.
ω-脒基苯基-α-氨基烷基羧酸的Nα-芳基磺酰化酰胺的同分异构体化合物——分别为Nα-脒基苯基磺酰化酰胺或ω-苯基-α-氨基烷基羧酸的Nα-芳基磺酰化脒基苯胺——与基本结构的衍生物相比具有较弱的抗凝血酶活性。因此,ω-脒基苯基-α-氨基烷基羧酸的某些衍生物具有高抗凝血酶活性是由特定的酶-抑制剂相互作用导致的这一假设得到了证实。相比之下,Nα-取代的ω-苯基-α-氨基烷基羧酸的脒基苯胺是胰蛋白酶和纤溶酶的有效抑制剂,它们的抑制活性接近Nα-取代的ω-脒基苯基-α-氨基烷基羧酸的伯酰胺的抑制活性。